跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lestremor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lestremor
Approved
STANDARD
Lestremor
Flamingo Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70f55c16b8553ae1
Company
Flamingo Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
70f55c16b8553ae1
Drug Approval Philippines Name
Lestremor
Product Name
Lestremor
Registration Number
DR-XY28093
Brand Name
Lestremor
Generic Name
Carbamazepine
Dosage Form
Tablet
Dosage Strength
200 mg
Manufacturer
Flamingo Pharmaceuticals Ltd.
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Issuance Date
28 September 2022
Expiry Date
25 November 2027
Pharmacologic Category
Anticonvulsant / Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70f55c16b8553ae1
Type
Standard
Back to Philippines FDA Approvals